Showing results (931-940 of 967) with videos related to

Sort By:
Pageof 97
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 31, 2020
Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, WashingtonSylvia M LaCourse, Alisa Kachikis, Michela Blain, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Live Imaging of SARS-CoV-2 Infection in Mice Reveals Neutralizing Antibodies Require Fc Function for Optimal EfficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Immunity|August 28, 2021
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacyIrfan Ullah, Jérémie Prévost, Mark S Ladinsky, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.
Journal of Virology|April 7, 2025
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaquesElise G Viox, Jonathan Richard, Andres G Grandea, et al.
Cell Host & Microbe|December 26, 2021
Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between dosesAlexandra Tauzin, Shang Yu Gong, Guillaume Beaudoin-Bussières, et al.
Neuron|February 1, 2025
Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunctionMilène Vandal, Adam Institoris, Louise Reveret, et al.
Nature Communications|December 1, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCCJonathan Richard, Michael W Grunst, Ling Niu, et al.
Pageof 97